P. Thangaraju, Himanshu Nirmal Chandu, Hemasri Velmurugan, S. Venkatesan
{"title":"Analysis of Research Publications on Leprosy Drugs Related Adverse Drug Reactions – A Scinetometric Study","authors":"P. Thangaraju, Himanshu Nirmal Chandu, Hemasri Velmurugan, S. Venkatesan","doi":"10.2174/1574885518666230731090607","DOIUrl":null,"url":null,"abstract":"\n\nLeprosy is curable and can be treated with multidrug therapy in the early stages. As a result,\nwe chose a Scientometrics evaluation of leprosy research guides on adverse drug reactions to better\ngrasp the current popularity of drug-related responses. During the 2010-2021 a study with a total of 48\npublications was selected. This study aims to analyze scientometric tools such as frequency distribution, percentage analysis, double-related growth rate, and interaction rate. During the study period, 7\n(14.58%) study publications were submitted in 2018. The related growth rate is identified by decreasing trend and the double time is growing from 2010 to 2021. The 11 published study sizes (22.92%)\nwere provided by top writers, the average Degree of Collaboration is 0.96, and 19 (39.58%) published\nresearch articles by headers. India is the largest supplier of 21 leprosy research publications (43.75%).\nAs India is the most productive country in leprosy research, hence there are four out of the top five institutions that are from the Indian center that is listed among the most productive institutions.\n","PeriodicalId":11004,"journal":{"name":"Current Drug Therapy","volume":" ","pages":""},"PeriodicalIF":0.3000,"publicationDate":"2023-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Drug Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1574885518666230731090607","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Leprosy is curable and can be treated with multidrug therapy in the early stages. As a result,
we chose a Scientometrics evaluation of leprosy research guides on adverse drug reactions to better
grasp the current popularity of drug-related responses. During the 2010-2021 a study with a total of 48
publications was selected. This study aims to analyze scientometric tools such as frequency distribution, percentage analysis, double-related growth rate, and interaction rate. During the study period, 7
(14.58%) study publications were submitted in 2018. The related growth rate is identified by decreasing trend and the double time is growing from 2010 to 2021. The 11 published study sizes (22.92%)
were provided by top writers, the average Degree of Collaboration is 0.96, and 19 (39.58%) published
research articles by headers. India is the largest supplier of 21 leprosy research publications (43.75%).
As India is the most productive country in leprosy research, hence there are four out of the top five institutions that are from the Indian center that is listed among the most productive institutions.
期刊介绍:
Current Drug Therapy publishes frontier reviews of high quality on all the latest advances in drug therapy covering: new and existing drugs, therapies and medical devices. The journal is essential reading for all researchers and clinicians involved in drug therapy.